1. Home
  2. AVXL vs NATH Comparison

AVXL vs NATH Comparison

Compare AVXL & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$4.19

Market Cap

430.9M

Sector

Health Care

ML Signal

HOLD

Logo Nathan's Famous Inc.

NATH

Nathan's Famous Inc.

HOLD

Current Price

$100.81

Market Cap

411.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVXL
NATH
Founded
2004
1916
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
430.9M
411.8M
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
AVXL
NATH
Price
$4.19
$100.81
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$22.00
N/A
AVG Volume (30 Days)
826.5K
28.6K
Earning Date
02-09-2026
02-05-2026
Dividend Yield
N/A
1.99%
EPS Growth
N/A
22.29
EPS
N/A
4.17
Revenue
N/A
$104,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$24.11
Revenue Growth
N/A
7.81
52 Week Low
$2.86
$88.00
52 Week High
$13.99
$118.32

Technical Indicators

Market Signals
Indicator
AVXL
NATH
Relative Strength Index (RSI) 39.48 54.82
Support Level $3.60 $100.25
Resistance Level $5.27 $101.86
Average True Range (ATR) 0.27 0.47
MACD -0.04 -0.10
Stochastic Oscillator 11.20 55.26

Price Performance

Historical Comparison
AVXL
NATH

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: